Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:brand |
gptkb:Inderal_LA
gptkb:Inno_Pran_XL |
| gptkbp:clinical_trial |
propranolol for PTSD
propranolol for anxiety propranolol for performance anxiety propranolol for thyroid storm propranolol for tremors |
| gptkbp:contraindication |
gptkb:asthma
heart block hypersensitivity to propranolol severe bradycardia |
| gptkbp:excretion |
urine
|
| gptkbp:formulation |
gptkb:software_framework
gptkb:tablet extended-release capsule |
| gptkbp:healthcare |
gptkb:1986
|
| https://www.w3.org/2000/01/rdf-schema#label |
Inderal
|
| gptkbp:ingredients |
propranolol
|
| gptkbp:interacts_with |
antidepressants
MAO inhibitors calcium channel blockers antiarrhythmics |
| gptkbp:is_atype_of |
C07 A A02
|
| gptkbp:is_used_for |
gptkb:musician
hypertension arrhythmias migraine prevention |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:lifespan |
3 to 6 hours
|
| gptkbp:manager |
oral
intravenous |
| gptkbp:manufacturer |
gptkb:temple
|
| gptkbp:metabolism |
liver
|
| gptkbp:scholarships |
avoid alcohol
do not stop abruptly monitor heart rate consult doctor before use in pregnancy may cause withdrawal symptoms |
| gptkbp:side_effect |
dizziness
fatigue nausea bradycardia cold extremities |
| gptkbp:social_structure |
C16 H21 N O2
|
| gptkbp:bfsParent |
gptkb:Propranolol
|
| gptkbp:bfsLayer |
6
|